Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Poodles of the World

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Faculty

Events

Resource Hubs

Chronic Total Occlusions (CTO): 60 Second Insights

Published: 08 March 2018

Views:
20
Likes:
7

Views:
20
Likes:
7
Share:

Now Playing
Part 5 | Session 6 of 7
Patrick Serruys
Patrick W Serruys

Up Next
Part 5 | Session 7 Gerald Werner
Gerald S Werner

Part 6 | Session 1 Ajay Kirtane
Ajay J Kirtane
Part 6 | Session 2 Simon Walsh
Simon J Walsh
Part 6 | Session 3 Paul Knaapen
Paul Knaapen
Part 6 | Session 4 Emmanouil Birkalis
Emmanouil S Brilakis
Part 6 | Session 5 Carlos Di Mario
Carlos Di Mario
Part 6 | Session 6 Patrick Serruys
Patrick W Serruys
Part 6 | Session 7 Gerald Werner
Gerald S Werner

Part 7 | Session 1 Ajay Kirtane
Ajay J Kirtane
Part 7 | Session 2 Simon Walsh
Simon J Walsh
Part 7 | Session 3 Paul Knaapen
Paul Knaapen
Part 7 | Session 4 Emmanouil Birkalis
Emmanouil S Brilakis
Part 7 | Session 5 Carlos Di Mario
Carlos Di Mario
Part 7 | Session 6 Patrick Serruys
Patrick W Serruys
Part 7 | Session 7 Gerald Werner
Gerald S Werner

Part 8 | Session 1 Ajay Kirtane
Ajay J Kirtane
Part 8 | Session 2 Simon Walsh
Simon J Walsh
Part 8 | Session 3 Paul Knaapen
Paul Knaapen
Part 8 | Session 4 Emmanouil Birlakis
Emmanouil S Brilakis
Part 8 | Session 5 Carlos Di Mario
Carlos Di Mario
Part 8 | Session 6 Patrick Serruys
Patrick W Serruys
Part 8 | Session 7 Gerald Werner
Gerald S Werner

Part 9 | Session 1 Ajay Kirtane
Ajay J Kirtane
Part 9 | Session 2 Simon Walsh
Simon J Walsh
Part 9 | Session 3 Paul Knaappen
Paul Knaapen
Part 9 | Session 4 Emmanouil Brilakis
Emmanouil S Brilakis
Part 9 | Session 5 Patrick Serruys
Patrick W Serruys
Part 9 | Session 6 Carlos Di Mario
Carlos Di Mario
Part 9 | Session 7 Gerald Werner
Gerald S Werner

Part 1 Ajay Kirtane Ajay J Kirtane

Part 2 | Session 1 Ajay Kirtane Ajay J Kirtane

Part 2 | Session 2 Simon Walsh Simon J Walsh

Part 2 | Session 3 Paul Knaapen Paul Knaapen

Part 2 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis

Part 2 | Session 5 Carlos Di Mario Carlos Di Mario

Part 2 | Session 6 Patrick Serruys Patrick W Serruys

Part 2 | Session 7 Gerald Werner Gerald S Werner

Part 3 | Session 1 Ajay Kirtane Ajay J Kirtane

Part 3 | Session 2 Simon Walsh Simon J Walsh

Part 3 | Session 3 Paul Knaapen Paul Knaapen

Part 3 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis

Part 3 | Session 5 Carlos Di Mario Carlos Di Mario

Part 3 | Session 6 Patrick Serruys Patrick W Serruys

Part 3 | Session 7 Gerald Werner Gerald S Werner

Part 4 | Session 1 Ajay Kirtane

Part 4 | Session 2 Simon Walsh Simon J Walsh

Part 4 | Session 3 Paul Knaapen Paul Knaapen

Part 4 | Session 4 Emmanouil Brilakis Emmanouil S Brilakis

Part 4 | Session 5 Patrick Serruys Patrick W Serruys

Part 4 | Session 6 Gerald Werner Gerald S Werner

Part 5 | Session 1 Ajay Kirtane Ajay J Kirtane

Part 5 | Session 2 Simon Walsh Simon J Walsh

Part 5 | Session 3 Paul Knaapen Paul Knaapen

Part 5 | Session 4 Emmanouil Birlakis Emmanouil S Brilakis

Part 5 | Session 5 Carlos Di Mario Carlos Di Mario

Average (ratings)

No ratings

Your rating

Overview

A series of 60-second interviews where Ajay Kirtane, Simon Walsh, Paul Knappen, Emmanouil Brilakis, Carlos Di Mario, Partick Serruys and Gerald Werner provide their thoughts on CTOs.

More from this programme

Part 1

Are CTOs important to the management of angina in your patients?

1 session
Ajay Kirtane	Watch now

Part 2

What trials are needed to advance the CTO field?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Brilakis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 3

What is your preferred imaging modality for CTOs?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Brilakis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 4

What is your preferred CTO wire strategy, and why?

6 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Brilakis	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 5

What is the biggest advance in CTO treatment in the past 5 years?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Birlakis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 6

What devices should be developed to further advance CTO management?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Birkalis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 7

The data for CTO is mixed, with clinical trials showing no clear benefit, should we keep on doing CTO's?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Birkalis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 8

Retrograde or anterograde? What is your preferred strategy?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaapen	Watch now
Emmanouil Birlakis	Watch now
Carlos Di Mario	Watch now
Patrick Serruys	Watch now
Gerald Werner	Watch now

Part 9

How would you recommend someone starts a CTO program?

7 sessions
Ajay Kirtane	Watch now
Simon Walsh	Watch now
Paul Knaappen	Watch now
Emmanouil Brilakis	Watch now
Patrick Serruys	Watch now
Carlos Di Mario	Watch now
Gerald Werner	Watch now

Faculty Biographies

Patrick W Serruys

Patrick W Serruys

Dr Patrick W Serruys has been a senior interventional cardiologist since 1977, Chief of Interventional Research since 1988, the Chief of Interventional Cardiology at the Thorax center from 1997-2012, Prof. of Medicine till April 1st 2014 at Erasmus MC.

Currently he is professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) of Imperial College in London (UK).

View full profile